10x Genomics, Inc. (TXG) Presents at Morgan Stanley 23rd Annual Global Healthcare

Core Insights - The past nine months have been eventful for 10x Genomics, marked by significant changes in the macro environment and various policy headwinds impacting end markets [1] Company Performance - The company started the year with strong momentum, but faced numerous challenges throughout the year [1] - The CEO expressed pride in the team's execution despite the ongoing difficulties and challenges encountered [1]